These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4633122)

  • 1. [Resistance of tubercle bacilli to rifampicin in experimental tuberculosis induced in laboratory animals].
    Janowiec M; Wierzejska H
    Gruzlica; 1973 Mar; 41(3):251-7. PubMed ID: 4633122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Virulence of rifampicin-resistant tubercle bacilli for experimental animals (preliminary report)].
    Osato T; Shimizu H
    Kekkaku; 1972 May; 47(5):129-34. PubMed ID: 4625370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin resistence and virulence of M. tuberculosis for guinea pigs].
    Schröder KH; Koperska C
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):112-3. PubMed ID: 4402403
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathomorphology of experimental tuberculosis induced by rifampicin-resistant mycobacteria].
    Vidin NB; El'shanskaia MP
    Probl Tuberk; 1972; 50(7):63-7. PubMed ID: 4626207
    [No Abstract]   [Full Text] [Related]  

  • 5. [The virulence of Mycobacterium tuberculosis strains resistant to rifampicin. (Preliminary note)].
    Daddi G; Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):29-33. PubMed ID: 4996681
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Virulence of rifampicin-resistent Mycobacterium tuberculosis].
    Klimenko MT
    Probl Tuberk; 1978 Jun; (6):73-7. PubMed ID: 97662
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critical concentration for definition of rifampicin resistance of tubercle bacilli].
    Tsukamura M
    Kekkaku; 1972 May; 47(5):113-9. PubMed ID: 4625369
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies for the determination of clinically available criteria of resistance of tubercle bacilli to rifampicin.
    Gomi J; Yanagisawa K; Murohashi T
    Kekkaku; 1970 Oct; 45(10):317-22. PubMed ID: 4991063
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Percentual content of Rifampicin-resistant mutants in the wild strains of tubercle bacilli isolated from patients untreated with rifampicin].
    Blitek-Golc D; Antosiewicz A; Zduńczyk-Pawelek H
    Gruzlica; 1972 Sep; 40(9):833-9. PubMed ID: 4631233
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical significance of the critical drug concentration of rifampicin. Report 1. Studies on the MIC of rifampicin to tubercle bacilli isolated from the rifampicin untreated patients using 1% Ogawa medium (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):1-5. PubMed ID: 815708
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1979 Feb; 54(2):89-92. PubMed ID: 108446
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of infection by drug resistant tubercle bacilli. 4. Experimental studies on infection by low-grade-resistant tubercle bacilli].
    Osato T; Kudo K; Aoki M
    Kekkaku; 1968 Dec; 43(12):503-8. PubMed ID: 4975467
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].
    Fabbrocini V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):435-40. PubMed ID: 4984548
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 19. [The critical concentration of clinical rifampicin resistance for tubercle bacilli and the acquirement pattern of rifampicin resistance of tubercle bacilli on Kirchner's semi-liquid agar media].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jun; 48(6):247-53. PubMed ID: 4200023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of rifampicin on experimental mouse tuberculosis].
    Yoshida F
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):35-43. PubMed ID: 4990960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.